Logotype for MBX Biosciences Inc

MBX Biosciences (MBX) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for MBX Biosciences Inc

Proxy filing summary

22 Apr, 2026

Voting matters and shareholder proposals

  • Election of two Class II Directors, Patrick J. Heron and Edward T. Mathers, to serve until the 2029 Annual Meeting or until successors are elected and qualified.

  • Ratification of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.

  • Additional business may be addressed if properly brought before the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends voting in favor of both director nominees and the auditor ratification.

Audit committee and external auditor matters

  • Proposal to ratify Ernst & Young LLP as the external auditor for the upcoming fiscal year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more